Marvel Biosciences Statistics
Total Valuation
TSXV:MRVL has a market cap or net worth of CAD 8.47 million. The enterprise value is 9.79 million.
Market Cap | 8.47M |
Enterprise Value | 9.79M |
Important Dates
The last earnings date was Wednesday, June 18, 2025.
Earnings Date | Jun 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSXV:MRVL has 52.95 million shares outstanding. The number of shares has increased by 11.06% in one year.
Current Share Class | 52.95M |
Shares Outstanding | 52.95M |
Shares Change (YoY) | +11.06% |
Shares Change (QoQ) | +4.33% |
Owned by Insiders (%) | 14.42% |
Owned by Institutions (%) | 10.37% |
Float | 44.46M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -2.90 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -6.07 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18
Current Ratio | 0.18 |
Quick Ratio | 0.18 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -9.38 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -196.43% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 60.13% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.50% in the last 52 weeks. The beta is 0.82, so TSXV:MRVL's price volatility has been lower than the market average.
Beta (5Y) | 0.82 |
52-Week Price Change | +37.50% |
50-Day Moving Average | 0.11 |
200-Day Moving Average | 0.13 |
Relative Strength Index (RSI) | 66.37 |
Average Volume (20 Days) | 58,835 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.33M |
Pretax Income | -1.61M |
Net Income | -1.61M |
EBITDA | n/a |
EBIT | -1.33M |
Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 389,016 in cash and 1.71 million in debt, giving a net cash position of -1.32 million or -0.02 per share.
Cash & Cash Equivalents | 389,016 |
Total Debt | 1.71M |
Net Cash | -1.32M |
Net Cash Per Share | -0.02 |
Equity (Book Value) | -2.93M |
Book Value Per Share | -0.06 |
Working Capital | -2.22M |
Cash Flow
Operating Cash Flow | -1.16M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TSXV:MRVL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.06% |
Shareholder Yield | n/a |
Earnings Yield | -19.04% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |